Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The current study will investigate whether the addition of Neuradiab to surgery, radiation and adjuvant chemotherapy (temozolomide) will improve the survival of patients with glioblastoma and whether the drug regimen is safe.
Epistemonikos ID: 8cf315fd07fd20c7750a193ec86b836d9390731b
First added on: May 04, 2024